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Introduction
Chronic Myeloid Leukemia (CML) is a myeloproliferative 
disorder which results in excessive production of granulocytic 
elements at every period of differentiation [1]. This results 
in infi ltration of blood, bone marrow and other tissue by 
neoplastic cells of granulocyte lineage [2]. Subjects are often 
diagnosed parenthetically when raised White Blood Cell count 
(WBC) is found on routine Complete Blood Count (CBC) or 
when splenomegaly is discovered during an abdominal exam 
or ultrasonography. Non-specifi c symptoms of giddiness, 
fatigability, and weight loss over a period of time may be 
encountered after the beginning of the ailment.
Ear manifestations have been discovered in 15-40% of 
leukemic patients [3-6]. These include moderate to profound 
sensorineural hearing loss (SNHL), tinnitus, giddiness, 
and facial nerve paresis. Less common features are related 
to granulocyte or platelet dysfunction such as infections, 
thrombosis or bleeding [7]. Rarely, patients present with 
leukostatic presentations such as irritability, headache, visual 
disturbance, ischemic stroke, cerebellar signs and priapism [8].
Hearing loss in conjunction with vestibular signs 
symptoms is rarely seen in CML as the fi rst manifestation. 
These symptoms can originate from hemorrhage, infi ltration 
by tumor cells, infection or leukostasis reactions [4].
Case Report
A 100yr old urology patient who was being managed as the 
case of Benign prostatic hypertrophy (BPH), present in ENT 
clinic with 3 month history of of generalized body weakness, 
dizziness and blurring of vision, with 2 hours history of bilateral 
Sudden hearing loss and tinnitus. No ear pain, exposure to 
loud noise, trauma to the ear, history of foreign body to the 
ear, facial pain and no history suggestive of nasal nor throat 
symptom. 
No bleeding from any of the craniofacial orifi ces and no 
prolonged bleeding from the punctured site. No contact with 
ionizing irradiations, and history suggestive of the respiratory 
symptom.
Not a known hypertensive, diabetic, peptic ulcer disease nor 
asthmatic patient. Nil history of surgery nor blood transfusion 
in the past.
The patient had been on Tablet Tamsulosin for 1 month 
prior to the onset of the hearing loss. 
Examination revealed an elderly man who was conscious 
and alert, pale, anicteric, acyanosed and not dehydrated. 
Vital signs were within normal limits. The Liver was about 
4-5cm down below the costal margin, while the Spleen was 
about 4-5cm down below the costal margin. Direct digital 
examination revealed mild prostate enlargement.
Abstract
Rapid progressive sensorineural hearing damage as the early sign of a hematological illness is 
often found in patients with Chronic Myeloid Leukemia. A 100-year- old man presented to our outpatient 
department with 2 hours history of bilateral sudden sensorineural hearing loss (SSNHL). After the 
hematological, bone marrow and radiological workup, the patient was found to have chronic myelogenous 
leukemia.
The patient was identifi ed as having unexplained SSNHL and was admitted for treatment, but his 
hematological investigations indicated that he had an undiagnosed form of leukemia. The possible 
pathogenesis of developing SSNHL from CML is discussed here within the report with highlights of 
differential diagnosis of SSNHL. 
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Otoscopic examination was essentially normal. However 
Pure Tone Audiometry (PTA) revealed bilateral mild-moderate 
sensorineural hearing loss (Figure 1).
Full blood count results were as follows: PCV=24%, 
WBC= WBC: 294.4 x 109/L,Blast cell=13%,Promyelocyte=9%, 
Myelocyte= 10%, Metamyelocyte=3%, Neutrophil=51%, 
Lymphocyte: 8%, Monocyte=2%, Basophil: 4%.
Peripheral blood fi lm showed a Chronic Myelod Leaukemic 
(CML) patient in accerated phase (Figure 2). Marked 
leucocytosis showing sheets of myeloid cell series. 
The myeloblast and promyelocyte make up to 18% of the 
total white blood cell. There was thrombocytosis.
Bone marrow aspiration indicated a Chronic Myeloid 
Leukemia (CML) patient in accelerated phase (Figure 3). There 
was Hypercellular marrow with Myeloid: Erythroid ratio 25:2.
Erythropoiesis was severely depressed. Myelopoiesis was 
markedly increased and showed sequential maturation along 
the myeloid series. There was increased Basophil and Eosinophil 
precursors, constituting about 20% of the nucleated marrow 
element. Lymphopoiesis was increased and Megakaryocytes 
were actively budding off platelets.
Magnetic Resonance imaging (MRI) of his brain showed 
hypodense third and lateral ventricle. He was commenced 
on routine therapy for CML: Allopurinol, cyclophosphamide, 
and hydroxyurea. Also added to the medication were neuron 
stimulants: Nicotinic acid and neurobion. The patient did well 
after 3 months and the hearing remarkedly improved.
Discussion
Hearing loss as a primary fi nding of CML is rare. Very few 
cases have been reported in works [9-12]. The pathogenesis 
of this entity appears to be multifactorial and includes various 
mechanisms such as leukostasis, leukemic infi ltration of 
the cochlea, hyperviscosity syndrome, thrombohemorrhagic 
complications, and infections.
Sudden sensorineural hearing loss (SSNHL) is an idiopathic 
condition of acute hearing injury with an incidence of 5 to 20 
per 100,000 persons in a year [13]. SSNHL is defi ned as hearing 
damage more than 30 dB at more than three consecutive 
frequencies developing within less than 3 days. Various reasons 
of SSNHL should be taken into account and assessed.
CML is a clonal disease, raised from an altered hematopoietic 
pluripotent stem cell causing an abundance of all cell lineages, 
particularly granulocytic one. This ailment is characterized by 
anemia, extremely elevated blood granulocytes, along with 
thrombocytosis and splenomegaly. The clinical commencement 
of illness is generally gradual and only <50% of subjects are 
symptomatic at the time of diagnosis.
Mechanism of deafness complaint symptom in leukemia 
is very complex, may comprise several mechanisms such 
as hyper-leucocytosis, affecting leukostasis and abnormal 
microvascular perfusion, leukemic infi ltration and infection 
[2]. In the 1970’s, Paparella et al. inspected the major series of 
temporal bones from subjects with different types of leukemia 
[4]. Autopsy cases from patients with acute myelogenous 
leukemia, chronic myelogenous leukemia, acute lymphocytic 
leukemia, and chronic lymphocytic leukemia demonstrated 
hemorrhage, leukemic infi ltration, infection, and reduced hair 
cells [4]. He observed that auditory complications develop 
earlier and more frequently in the acute than the chronic 
leukemias [4].
This subject presented with SSNHL and visual blurring 
as the clinical symptom of a leukostatic reaction of CML like 
some published studies [14-16]. Most problems in conjunction 
with leukostatic reaction are recoverable with a rapid drop in 
the leukocyte count by plasmapheresis. Hearing loss is likely 
due to the leukostatic reaction resulting in occlusion of the 
labyrinthine artery resulting in irreversible SSNHL despite a 
rapid drop of leukocyte count [14]. Some cases of SSNHL in 
CML may be improved by cytoreduction and chemotherapy. 
But regrettably, we did not detect enhancement in our subject. 
Figure 1: Pure Tone Audiometry showing a bilateral mild-moderate hearing loss. 
Figure 2: Peripheral blood fi lm of a Chronic Myelod Leaukemic (CML) patient in 
accerated phase.Marked leucocytosis with sheets of myeloid cell series.
Figure 3: Bone marrow aspiration showing hypercellular marrow with Myeloid: 
Erythroid ratio 25:2. Erythropoiesis is severely depressed. 
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The absence of improving hearing symptom in our patient 
most probably happened as a result of hyper-leucocytosis with 
resultant leukostasis reaction and blocking of labyrinthine and 
other small arteries of the vertebro-basilar region. This case 
demonstrates the utmost importance of follow-up.
Conclusion
SSNHL as an initial symptom of CML is very rare. Our 
patient presented with sudden deafness when the white 
blood cell count had increased to 294.4x109/L, making hyper-
leucocytosis as a likely cause. Imaging of his brain showed 
hypodense third and lateral ventricle which was assessed as 
benign intracranial hypertension. Therefore, it is likely that as 
a result of leukostasis reaction labyrinthine and other small 
arteries were blocked resulting in SSNHL.
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